Raiffeisen Bank International
WST icon

Raiffeisen Bank International’s West Pharmaceutical WST Stock Holding History

Raiffeisen Bank International’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.2K Buy
133
+65
+96% +$19.9K ﹤0.01% 592
2026
Q1 		$16.7K Hold
68
– – ﹤0.01% 667
2025
Q4 		$18.8K Hold
68
– – ﹤0.01% 627
2025
Q3 		$17.7K Buy
+68
New +$16.5K ﹤0.01% 635
2025
Q1 		– Sell
-674
Closed -$222K – 644
2024
Q4 		$222K Buy
+674
New +$212K ﹤0.01% 429

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Generation Investment Management
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Raiffeisen Bank International's WST Position: Q2 2026 in Review

Raiffeisen Bank International increased its West Pharmaceutical (WST) stake by 96% in Q2 2026, buying an estimated $19.9K and bringing the position to 133 shares worth $47.2K. The position accounts for ﹤0.01% of the portfolio, ranked #592.

Raiffeisen Bank International first reported a position in WST in Q4 2024 and has held it in 5 quarters since. The position peaked at $222K in Q4 2024. 835 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Raiffeisen Bank International held 133 shares of West Pharmaceutical worth $47.2K as of Q2 2026.
  • Raiffeisen Bank International bought 65 West Pharmaceutical shares in Q2 2026, an estimated $19.9K.
  • West Pharmaceutical made up ﹤0.01% of Raiffeisen Bank International's portfolio in Q2 2026, its #592 holding.
  • Raiffeisen Bank International first reported a position in West Pharmaceutical in Q4 2024 and has held it in 5 quarters since.
  • Raiffeisen Bank International's West Pharmaceutical position peaked at $222K in Q4 2024.
  • 835 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.